Fundus autofluorescence in patients with macular holes imaged with a laser scanning ophthalmoscope.

PubWeight™: 0.94‹?›

🔗 View Article (PMC 1722560)

Published in Br J Ophthalmol on April 01, 1998

Authors

A von Rückmann1, F W Fitzke, Z J Gregor

Author Affiliations

1: Moorfields Eye Hospital, London.

Articles cited by this

Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophthalmol (1991) 7.00

Idiopathic senile macular hole. Its early stages and pathogenesis. Arch Ophthalmol (1988) 5.74

In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci (1995) 5.29

Optical coherence tomography of macular holes. Ophthalmology (1995) 4.64

Fluorescein angiography complication survey. Ophthalmology (1986) 2.96

Idiopathic macular holes. Observations, stages of formation, and implications for surgical intervention. Ophthalmology (1988) 2.31

Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope. Invest Ophthalmol Vis Sci (1997) 2.31

Vitrectomy for prevention of macular holes. Results of a randomized multicenter clinical trial. Vitrectomy for Prevention of Macular Hole Study Group. Ophthalmology (1994) 2.01

Clinicopathologic study of bilateral macular holes treated with pars plana vitrectomy and gas tamponade. Retina (1992) 1.91

Transforming growth factor beta. A biologic chorioretinal glue. Arch Ophthalmol (1989) 1.71

Human autologous serum for the treatment of full-thickness macular holes. A preliminary study. Ophthalmology (1995) 1.69

Transforming growth factor-beta 2 for the treatment of full-thickness macular holes. A prospective randomized study. Ophthalmology (1992) 1.63

Differentiating macular holes from macular pseudoholes. Am J Ophthalmol (1994) 0.99

Surgical treatment of full-thickness macular holes using autologous serum. Eye (Lond) (1996) 0.93

A prospective natural history study and kinetic ultrasound evaluation of idiopathic macular holes. Ophthalmology (1994) 0.93

Subjective slitbeam sign for macular disease. Am J Ophthalmol (1969) 0.90

Macular pseudoholes. Clinical features and accuracy of diagnosis. Ophthalmology (1992) 0.89

[Static microperimetry with the laser scanning ophthalmoscope]. Ophtalmologie (1991) 0.84

Fluorescein angiographic characteristics of macular holes before and after vitrectomy with transforming growth factor beta-2. Am J Ophthalmol (1994) 0.82

Articles by these authors

(truncated to the top 100)

Mapping the visual field to the optic disc in normal tension glaucoma eyes. Ophthalmology (2000) 4.56

Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br J Ophthalmol (1995) 3.62

Variation of nerve fibre layer thickness measurements with age and ethnicity by scanning laser polarimetry. Br J Ophthalmol (1997) 3.55

Early detection of visual field progression in glaucoma: a comparison of PROGRESSOR and STATPAC 2. Br J Ophthalmol (1997) 2.88

Recognition of vitreoschisis in proliferative diabetic retinopathy. A useful landmark in vitrectomy for diabetic traction retinal detachment. Ophthalmology (1996) 2.36

Scaling the hill of vision: the physiological relationship between light sensitivity and ganglion cell numbers. Invest Ophthalmol Vis Sci (2000) 2.33

Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope. Invest Ophthalmol Vis Sci (1997) 2.31

Simple retinal detachments: identifying the at-risk case. Eye (Lond) (2002) 2.26

Measurement of optic disc size: equivalence of methods to correct for ocular magnification. Br J Ophthalmol (1998) 2.20

In vivo fundus autofluorescence in macular dystrophies. Arch Ophthalmol (1997) 2.10

Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus. Arch Ophthalmol (2001) 2.04

Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy. Arch Ophthalmol (1998) 1.93

Effect of surgery on visual field progression in normal-tension glaucoma. Ophthalmology (1997) 1.84

Functional characterisation and serial imaging of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. Br J Ophthalmol (2006) 1.74

Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol (2000) 1.73

Macular hole opercula. Ultrastructural features and clinicopathological correlation. Arch Ophthalmol (1997) 1.73

Acute zonal occult outer retinopathy: towards a set of diagnostic criteria. Br J Ophthalmol (2005) 1.70

Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. Invest Ophthalmol Vis Sci (1992) 1.69

Prophylactic argon laser retinopexy prior to removal of silicone oil: a pilot study. Eye (Lond) (1997) 1.67

Model for deriving the optical performance of the myopic eye corrected with an intracorneal ring. J Refract Surg (1996) 1.64

Optic disc changes following trabeculectomy: longitudinal and localisation of change. Br J Ophthalmol (2001) 1.61

Silicone oil removal. II. Operative and postoperative complications. Br J Ophthalmol (1987) 1.58

Modelling series of visual fields to detect progression in normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol (1995) 1.56

Refractive index of the human corneal epithelium and stroma. J Refract Surg (1995) 1.55

Symptomatic abnormalities of dark adaptation in patients with age-related Bruch's membrane change. Br J Ophthalmol (1993) 1.51

Pneumatic retinopexy in the treatment of primary rhegmatogenous retinal detachment. Eye (Lond) (1999) 1.47

The use of corticosteroids for choroidal neovascularisation in young patients. Eye (Lond) (1998) 1.43

Severity and stability of glaucoma: patient perception compared with objective measurement. Arch Ophthalmol (1999) 1.40

Functional correlates of fundus autofluorescence abnormalities in patients with RPGR or RIMS1 mutations causing cone or cone rod dystrophy. Br J Ophthalmol (2007) 1.40

Surgical removal of choroidal neovascular membranes after laser photocoagulation for diabetic maculopathy. Eye (Lond) (2001) 1.38

Transversal and longitudinal images from the retina of the living eye using low coherence reflectometry. J Biomed Opt (1998) 1.36

Visual field progression: comparison of Humphrey Statpac2 and pointwise linear regression analysis. Graefes Arch Clin Exp Ophthalmol (1996) 1.35

Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation. Br J Ophthalmol (1996) 1.35

Distribution of pigment epithelium autofluorescence in retinal disease state recorded in vivo and its change over time. Graefes Arch Clin Exp Ophthalmol (1999) 1.34

Simulating binocular visual field status in glaucoma. Br J Ophthalmol (1998) 1.32

Confocal imaging of the fundus using a scanning laser ophthalmoscope. Br J Ophthalmol (1992) 1.32

Silicone oil removal. I. The effect on the complications of silicone oil. Br J Ophthalmol (1987) 1.30

Quantitative evaluation of fundus autofluorescence imaged "in vivo" in eyes with retinal disease. Br J Ophthalmol (2000) 1.29

Visual field loss following vitrectomy for stage 2 and 3 macular holes. Br J Ophthalmol (1996) 1.25

Systemic risk factors for idiopathic macular holes: a case-control study. Eye (Lond) (1998) 1.25

Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy. Br J Ophthalmol (2000) 1.24

Autosomal dominant cone-rod dystrophy with mutations in the guanylate cyclase 2D gene encoding retinal guanylate cyclase-1. Arch Ophthalmol (2001) 1.24

In vivo morphometry of the lamina cribrosa and its relation to visual field loss in glaucoma. Curr Eye Res (1998) 1.23

Macular microholes: pathogenesis and natural history. Br J Ophthalmol (2005) 1.22

Autosomal dominant cone and cone-rod dystrophy with mutations in the guanylate cyclase activator 1A gene-encoding guanylate cyclase activating protein-1. Arch Ophthalmol (2001) 1.22

Abnormal dark adaptation kinetics in autosomal dominant sector retinitis pigmentosa due to rod opsin mutation. Br J Ophthalmol (1992) 1.20

Autosomal dominant cone-rod retinal dystrophy (CORD6) from heterozygous mutation of GUCY2D, which encodes retinal guanylate cyclase. Ophthalmology (2000) 1.20

Abnormal dark adaptation and rhodopsin kinetics in Sorsby's fundus dystrophy. Invest Ophthalmol Vis Sci (1992) 1.19

Use of sequential Heidelberg retina tomograph images to identify changes at the optic disc in ocular hypertensive patients at risk of developing glaucoma. Br J Ophthalmol (2000) 1.16

A practical approach to measuring the visual field component of fitness to drive. Br J Ophthalmol (2004) 1.14

Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivo. Cell Death Dis (2010) 1.13

A detailed phenotypic study of "cone dystrophy with supernormal rod ERG". Br J Ophthalmol (2005) 1.13

Bimodal expressivity in dominant retinitis pigmentosa genetically linked to chromosome 19q. Br J Ophthalmol (1995) 1.12

Night vision after excimer laser photorefractive keratectomy: haze and halos. Eur J Ophthalmol (1994) 1.12

Intrafamilial variation of phenotype in Stargardt macular dystrophy-Fundus flavimaculatus. Invest Ophthalmol Vis Sci (1999) 1.11

Quantification of lens opacification with a commercially available lensometer. Br J Ophthalmol (1990) 1.09

Migrating scleral explants. Eye (Lond) (1992) 1.07

Interobserver agreement on visual field progression in glaucoma: a comparison of methods. Br J Ophthalmol (2003) 1.06

Retinitis pigmentosa and retinal neovascularization. Ophthalmology (1986) 1.06

Inflammatory cells in proliferative vitreoretinopathy subretinal membranes. Ophthalmology (1993) 1.05

Long-term effect of acetazolamide in a patient with retinitis pigmentosa. Invest Ophthalmol Vis Sci (1990) 1.03

Phenotype of a British North Carolina macular dystrophy family linked to chromosome 6q. Br J Ophthalmol (1998) 1.03

A detailed study of the phenotype of an autosomal dominant cone-rod dystrophy (CORD7) associated with mutation in the gene for RIM1. Br J Ophthalmol (2005) 1.02

En face optical coherence tomography: a new method to analyse structural changes of the optic nerve head in rat glaucoma. Br J Ophthalmol (2005) 1.02

Magnification characteristics of fundus imaging systems. Ophthalmology (1998) 1.02

Clinical features of codon 172 RDS macular dystrophy: similar phenotype in 12 families. Arch Ophthalmol (1999) 1.02

Corneal astigmatism following cataract extraction. Br J Ophthalmol (1986) 1.01

Vanishing retinal arterial aneurysms: a case report. Br J Ophthalmol (1992) 1.01

Angiopoietin concentrations in diabetic retinopathy. Br J Ophthalmol (2005) 1.01

Retinal dysfunction in central serous retinopathy. Eye (Lond) (1987) 1.00

Image size in the fundus: structural evidence for wide-field retinal magnification factor. Br J Ophthalmol (1988) 1.00

Sorsby's pseudoinflammatory macula dystrophy--Sorsby's fundus dystrophies. Eye (Lond) (1988) 1.00

Refractive sectors in the visual field of the pigeon eye. J Physiol (1985) 1.00

Quantitative analysis of the lamina cribrosa in vivo using a scanning laser opthalmoscope. Curr Eye Res (1997) 1.00

A prospective study of the effect of a unilateral macular hole on sensory and motor binocular function and recovery following successful surgery. Br J Ophthalmol (2004) 1.00

Disturbances in night vision after excimer laser photorefractive keratectomy. Eye (Lond) (1994) 1.00

Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 2 Visual field progression. Br J Ophthalmol (2001) 1.00

New approach to estimating variability in visual field data using an image processing technique. Br J Ophthalmol (1995) 0.99

Effect of decreased retinal illumination on frequency doubling technology. Jpn J Ophthalmol (2000) 0.98

Removal of silicone oil following diabetic vitrectomy. Br J Ophthalmol (1993) 0.97

Dominant retinitis pigmentosa associated with two rhodopsin gene mutations. Leu-40-Arg and an insertion disrupting the 5'-splice junction of exon 5. Arch Ophthalmol (1993) 0.97

Imaging apoptosis in the eye. Eye (Lond) (2011) 0.96

Functional aspects of drusen regression in age-related macular degeneration. Br J Ophthalmol (2009) 0.95

An atypical phenotype of macular and peripapillary retinal atrophy caused by a mutation in the RP2 gene. Br J Ophthalmol (2004) 0.93

Surgical treatment of full-thickness macular holes using autologous serum. Eye (Lond) (1996) 0.93

Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy. Eye (Lond) (2006) 0.93

Visual and anatomical results of surgery for long standing macular holes. Br J Ophthalmol (2000) 0.93

Incidence of idiopathic full-thickness macular holes in fellow eyes. A 5-year prospective natural history study. Ophthalmology (1998) 0.92

Autosomal dominant pattern dystrophy of the retina associated with a 4-base pair insertion at codon 140 in the peripherin/RDS gene. Arch Ophthalmol (1995) 0.92

Dark adaptation and scotopic perimetry over 'peau d'orange' in pseudoxanthoma elasticum. Br J Ophthalmol (1994) 0.91

Laser treatment in subjects with high-risk clinical features of age-related macular degeneration. Posterior pole appearance and retinal function. Arch Ophthalmol (1997) 0.91

Halos--a problem for all myopes? A comparison between spectacles, contact lenses, and photorefractive keratectomy. Refract Corneal Surg (1993) 0.91

Chromosome 19q cone-rod retinal dystrophy. Ocular phenotype. Arch Ophthalmol (1995) 0.90

Use of high spatial resolution perimetry to identify scotomata not apparent with conventional perimetry in the nasal field of glaucomatous subjects. Br J Ophthalmol (2002) 0.90

Experimental myopia in chicks: ocular refraction by electroretinography. Invest Ophthalmol Vis Sci (1985) 0.90

Fundus autofluorescence imaging compared with different confocal scanning laser ophthalmoscopes. Br J Ophthalmol (2003) 0.90

Characterisation of the macular dystrophy in patients with the A3243G mitochondrial DNA point mutation with fundus autofluorescence. Br J Ophthalmol (2008) 0.90

High spatial resolution automated perimetry in glaucoma. Br J Ophthalmol (1997) 0.90

Acute macular neuroretinopathy. Ophthalmology (1989) 0.90

Comparison of visual field progression in patients with normal pressure glaucoma between eyes with and without visual field loss that threatens fixation. Br J Ophthalmol (2000) 0.89